LLY

775.15

-2.1%↓

JNJ

152.39

+0.45%↑

ABBV

184.42

-0.99%↓

NVO

68.11

+0.95%↑

UNH

306.72

+1.67%↑

LLY

775.15

-2.1%↓

JNJ

152.39

+0.45%↑

ABBV

184.42

-0.99%↓

NVO

68.11

+0.95%↑

UNH

306.72

+1.67%↑

LLY

775.15

-2.1%↓

JNJ

152.39

+0.45%↑

ABBV

184.42

-0.99%↓

NVO

68.11

+0.95%↑

UNH

306.72

+1.67%↑

LLY

775.15

-2.1%↓

JNJ

152.39

+0.45%↑

ABBV

184.42

-0.99%↓

NVO

68.11

+0.95%↑

UNH

306.72

+1.67%↑

LLY

775.15

-2.1%↓

JNJ

152.39

+0.45%↑

ABBV

184.42

-0.99%↓

NVO

68.11

+0.95%↑

UNH

306.72

+1.67%↑

Search

Dr Reddy's Laboratories Ltd-ADR

Avatud

SektorTervishoid

15.07 -2.02

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

14.96

Max

15.37

Põhinäitajad

By Trading Economics

Sissetulek

1.8B

16B

Müük

1.5B

85B

P/E

Sektori keskmine

19.628

50.291

Aktsiakasum

19.11

Dividenditootlus

0.62

Kasumimarginaal

18.66

Töötajad

27,811

EBITDA

985M

25B

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+10.24% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.62%

2.40%

Turustatistika

By TradingEconomics

Turukapital

10B

13B

Eelmine avamishind

17.09

Eelmine sulgemishind

15.07

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

Dr Reddy's Laboratories Ltd-ADR Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

9. mai 2025, 18:56 UTC

Tulu

Dr Reddy's Laboratories 4Q EPS INR19.11 >RDY

9. mai 2025, 18:56 UTC

Tulu

Dr Reddy's Laboratories 4Q Rev INR85.06B >RDY

23. jaan 2025, 17:46 UTC

Tulu

Dr. Reddy's 3Q Net Attributable to Equity Holders of Parent Company INR14.13B

23. jaan 2025, 17:42 UTC

Tulu

Dr. Reddy's 3Q Rev INR83.59B

5. nov 2024, 11:01 UTC

Tulu

Dr. Reddy's Laboratories 1H Rev INR156.89B Vs. INR136.19B >RDY

5. nov 2024, 11:00 UTC

Tulu

Dr. Reddy's Laboratories 1H Net INR26.47B Vs. Net INR28.825B >RDY

5. nov 2024, 10:57 UTC

Tulu

Dr. Reddy's Laboratories 2Q Net INR12.55B Vs. Net INR14.80B >RDY

5. nov 2024, 10:57 UTC

Tulu

Dr. Reddy's Laboratories 2Q Rev INR80.16B Vs. INR68.80B >RDY

Võrdlus sarnastega

Hinnamuutus

Dr Reddy's Laboratories Ltd-ADR Prognoos

Hinnasiht

By TipRanks

10.24% tõus

12 kuu keskmine prognoos

Keskmine 16.9 USD  10.24%

Kõrge 16.9 USD

Madal 16.9 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Dr Reddy's Laboratories Ltd-ADR 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

1

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

N/A / 13.84Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Weak Bullish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Dr Reddy's Laboratories Ltd-ADR

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The company offers its products for various therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.